VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve 1. Audited financial results for the quarter and year ended 31.03.2024.
2. Audit Report for quarter and year ended 31.03.2024.
3. Conversion of warrants into equity shares of the Company to the Non-Promoters, subject to the depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company.
4. Any other business with the permission of the Chair.
|